Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis

Lancet Regional Health - Western Pacific, The - Tập 32 - Trang 100666 - 2023
Xiaozhen Lai1,2, Cristina Garcia3,4, Dan Wu5, Maria Deloria Knoll3,4, Haijun Zhang1,2, Tingting Xu6, Rize Jing7, Zundong Yin5, Brian Wahl3,4, Hai Fang1,8,9
1China Center for Health Development Studies, Peking University, Beijing, China
2Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China
3Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
4International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
5National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China
6Department of Health Management and Policy, School of Public Health, Capital Medical University, Beijing, China
7School of Public Administration and Policy, Renmin University of China, Beijing, China
8Peking University Health Science Center, Chinese Center for Disease Control and Prevention Joint Research Center for Vaccine Economics, Beijing, China
9Institute for Global Health and Development, Peking University, Beijing, China

Tài liệu tham khảo

2019 O'Brien, 2009, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates, Lancet, 374, 893, 10.1016/S0140-6736(09)61204-6 He, 2017, National and subnational all-cause and cause-specific child mortality in China, 1996-2015: a systematic analysis with implications for the Sustainable Development Goals, Lancet Global Health, 5, e186, 10.1016/S2214-109X(16)30334-5 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1 Wahl, 2018, Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15, Lancet Global Health, 6, e744, 10.1016/S2214-109X(18)30247-X Lai, 2022, National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: modelled estimates for 2010-17, Lancet Reg Health West Pac, 22 Yu, 2012, To save children's lives, China should adopt an initiative to speed introduction of pneumonia vaccines, Health Aff (Millwood), 31, 2545, 10.1377/hlthaff.2011.1272 Waight, 2015, Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study, Lancet Infect Dis, 15, 535, 10.1016/S1473-3099(15)70044-7 Marom, 2021, Pneumococcal conjugated vaccines decreased acute otitis media burden: a population-based study in Israel, J Pediatr, 235, 233, 10.1016/j.jpeds.2021.04.025 WHO WB WB Zhou, 2019, Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 394, 1145, 10.1016/S0140-6736(19)30427-1 Song, 2016, Causes of death in children younger than five years in China in 2015: an updated analysis, J Glob Health, 6 Watt, 2009, Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates, Lancet, 374, 903, 10.1016/S0140-6736(09)61203-4 Eke, 2016, Epidemiology of congenital anomalies of the central nervous system in children in Enugu, Nigeria: a retrospective study, Ann Afr Med, 15, 126, 10.4103/1596-3519.188892 Edmond, 2010, Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis, Lancet Infect Dis, 10, 317, 10.1016/S1473-3099(10)70048-7 Sun, 2015, Investigation on neonatal hearing screening status in Zhengzhou, 2009–2013, Matern Child Health Care China, 30, 571 Ministry of education of the people's Republic of China, 2018 Lucero, 2009, Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age, Cochrane Database Syst Rev, 2009, Cd004977 Eskola, 2001, Efficacy of a pneumococcal conjugate vaccine against acute otitis media, N Engl J Med, 344, 403, 10.1056/NEJM200102083440602 Knoll, 2021, Conclusions from the PSERENADE project: implications for pneumococcal vaccine policy and what is happening next CHIRA 2020 Qiu, 2017, Cost-effectiveness of pediatric cochlear implantation in rural China, Otol Neurotol, 38, e75, 10.1097/MAO.0000000000001389 2018 Bennett, 2000, Parents' utilities for outcomes of occult bacteremia, Arch Pediatr Adolesc Med, 154, 43 Van Hoek, 2012, The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England, Vaccine, 30, 7205, 10.1016/j.vaccine.2012.10.017 Oh, 1996, A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children, Clin Therapeut, 18, 160, 10.1016/S0149-2918(96)80188-3 Oostenbrink, 2002, The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison, J Clin Epidemiol, 55, 791, 10.1016/S0895-4356(02)00448-1 Yu, 2018, Routine immunization services costs and financing in China, 2015, Vaccine, 36, 3041, 10.1016/j.vaccine.2018.04.008 Li, 2020, Surveillance of adverse events following immunization in China, 2017, Chin J Vaccines Immunization, 26, 9 2020 Moïsi, 2009, Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study, Clin Infect Dis, 48, S49, 10.1086/596481 Liu, 2016 Ning, 2017, Retrospective investigation on diseases burden of children with community acquired pneumonia under 5 Years in baiyin city of Gansu province, 2015-2016, Chin J Vaccines Immunization, 23, 18 Lai, 2020, Willingness to pay for seasonal influenza vaccination among children, chronic disease patients, and the elderly in China: a national cross-sectional survey, Vaccines (Basel, 8, 405, 10.3390/vaccines8030405 2001 Cai, 2021, Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life, Eur J Health Econ, 23, 10.1007/s10198-021-01384-z Maurer, 2016, Cost-effectiveness analysis of pneumococcal vaccination for infants in China, Vaccine, 34, 6343, 10.1016/j.vaccine.2016.10.051 Shen, 2018, Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China, PLoS One, 13, 10.1371/journal.pone.0201245 Zhou, 2018, Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants, Hum Vaccines Immunother, 14, 1444, 10.1080/21645515.2018.1438794 Mo, 2016, Cost-effectiveness and health benefits of pediatric 23-valent pneumococcal polysaccharide vaccine, 7-valent pneumococcal conjugate vaccine and forecasting 13-valent pneumococcal conjugate vaccine in China, Pediatr Infect Dis J, 35, e353, 10.1097/INF.0000000000001288 Levine, 2010, Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions, Curr Opin Infect Dis, 23, 236, 10.1097/QCO.0b013e328338c135
Thông tin
Thông tin xuất bản

Lancet Regional Health - Western Pacific, The

Tập 32

100666

Thông tin tác giả